Ocuphire Pharma(OCUP) - 2024 Q3 - Quarterly Results

Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among: OCUPHIRE PHARMA, INC. a Delaware corporation; ORANGE MERGER SUB I, INC., a Delaware corporation; ORANGE MERGER SUB II, LLC, a Delaware limited liability company; and OPUS GENETICS INC. a Delaware corporation Dated as of October 22, 2024 THIS MERGER AGREEMENT IS SUBJECT TO REVISION BY THE PARTIES AT ANY TIME AND MUST BE KEPT CONFIDENTIAL IN ACCORDANCE WITH THE TERMS OF THE CONFIDENTIALITY AGREEMENT ENTERED INTO BETWEEN THE PARTIES. THIS DOCUMENT HAS BEEN PREPAR ...